简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Rapid Micro BiomSystems报告第一季度业绩

2025-05-09 19:49

  • Rapid Micro Biosystems press release (NASDAQ:RPID): Q1 reports total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024.
  • Reports record quarterly service revenue led by strong validation activity.
  • Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.
  • Net loss for the first quarter of 2025 was $11.3 million, compared to $13.3 million in the first quarter of 2024. Net loss per share for the first quarter of 2025 was $0.26, compared to $0.31 in the first quarter of 2024.
  • Cash, cash equivalents and short-term investments were approximately $42 million, and the Company had no debt outstanding as of March 31, 2025.
  • 2025 Outlook: The Company is reaffirming its full year 2025 total revenue guidance of at least $32.0 million, with between 21 and 25 system placements.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。